Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents

Fostamatinib is a tyrosine kinase inhibitor with activity against spleen tyrosine kinase which has completed clinical trials for patients with rheumatoid arthritis. In clinical studies fostamatinib treatment was associated with a small elevation of systemic arterial blood pressure (BP), a similar fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lengel, Dave, Lamm Bergström, Eva, Barthlow, Herb, Oldman, Karen, Musgrove, Helen, Harmer, Alex, Valentin, Jean-Pierre, Duffy, Paul, Braddock, Martin, Curwen, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618647/
https://www.ncbi.nlm.nih.gov/pubmed/26516588
http://dx.doi.org/10.1002/prp2.176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618647/
https://www.ncbi.nlm.nih.gov/pubmed/26516588
http://dx.doi.org/10.1002/prp2.176

Ejemplares similares